Etomidate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Etomidate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 10/05/2022. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-6695-02
- Dosage Form
- Injection
- Presentation
- Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)
- Initial Posting
- 10/05/2022
- Revised Date
Reason
Other